Priapism in hypogonadal men receiving gonadotropin releasing hormone.
To our knowledge we report the first 2 cases of priapism occurring in hypogonadal men receiving gonadotropin releasing hormone therapy. Hypogonadal patients receiving hormonal therapy should be informed about the possibility of priapism and the importance of early urological consultation.
Whalen
R K
RK
Department of Urology, Massachusetts General Hospital, Harvard Medical School, Boston.
Whitcomb
R W
RW
Crowley
W F
WF
McGovern
F J
FJ
D004334:Drug Administration Schedule; D007987:Gonadotropin-Releasing Hormone / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D007006:Hypogonadism / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D010410:Penile Erection / Q000502:physiology; D011317:Priapism / Q000139:chemically induced*; D013739:Testosterone / Q000502:physiology
D007987:Gonadotropin-Releasing Hormone; D013739:Testosterone